GPT and inflammatory bowel disease: Eight participants withdrew before challenge (four in the Vi-TT group, two in the Vi-PS group, and two in the control group), six withdrew consent due to changes in personal circumstances affecting study visit availability, one participant was diagnosed with inflammatory bowel disease (symptoms preceded study enrolment), and one participant was excluded due to persistently increased alanine aminotransferase concentrations.